Finance

Lists
EMMA:OTCMKTS
Emmaus Life Sciences Inc
$0.068
+22.85%
(+0.013) 1D
Sep 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EMMA...
Open
$0.06
High
$0.07
Low
$0.06
Mkt. cap
4.77M
Avg. vol.
244.35K
Volume
110.89K
52-wk high
$0.09
52-wk low
$0.01
EPS
-$0.10
Beta
2.26
Shares outstanding
550.00K
No. of employees
13
Open
$0.06
High
$0.07
Low
$0.06
Mkt. cap
4.77M
Avg. vol.
244.35K
Volume
110.89K
52-wk high
$0.09
52-wk low
$0.01
EPS
-$0.10
Beta
2.26
Shares outstanding
550.00K
No. of employees
13
About Emmaus Life Sciences Inc
CEO-
Employees13
Founded1987
HeadquartersAliso Viejo, California, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.38M
3.85M
1.98M
6.32M
Cost of goods sold
247.00K
235.00K
168.00K
344.00K
Cost of revenue
247.00K
235.00K
168.00K
344.00K
Research and development expenses
50.00K
31.00K
40.00K
116.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.90M
3.18M
2.60M
2.07M
Operating expense
1.95M
3.21M
2.64M
2.18M
Total operating expenses
2.20M
3.45M
2.80M
2.53M
Operating income
1.18M
402.50K
-823.00K
3.79M
Other non operating income
2.00K
-863.00K
-237.00K
238.00K
EBT including unusual items
-1.50M
-1.94M
-3.33M
1.34M
EBT excluding unusual items
-717.50K
-2.59M
-3.26M
2.49M
Income tax expense
579.00K
16.00K
4.00K
-1.00K
Effective tax rate
-38.68%
-0.83%
-0.12%
-0.07%
Other operating expenses
-
-
-
-
Net income
-2.08M
-1.95M
-3.34M
1.34M
Net profit margin
-61.46%
-50.65%
-168.26%
21.19%
Earnings per share
-
-
-
-
Interest and investment income
65.00K
65.00K
61.00K
49.00K
Interest expense
-1.93M
-2.27M
-2.13M
-1.60M
Net interest expenses
-1.87M
-2.20M
-2.06M
-1.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.19M
417.50K
-808.00K
3.80M
Gain or loss from assets sale
-
-861.00K
-
-
AI content may include mistakes. Learn more
Google apps